Strona główna
  • Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka

Rapid Reference to Schizophrenia

Rapid Reference Series

9780723433163
60,43 zł
54,39 zł Zniżka 6,04 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 54,39 zł
Ilość
Produkt niedostępny
Nakład wyczerpany (niedostępny u wydawcy)

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
Rapid Reference to Schizophrenia will provide the reader with authoritative and accessible information from a clinical expert in the field, to assist with treatment decisions. Each title in the new Rapid Reference series provides standard core content (epidemiology - management/ therapy) combined with the additional information, such as FAQs and patient organisations, needed by the GP to provide effective patient care. They also include drugs listings, clinical trials, information on future developments and web site listings to keep the reader up to speed with new developments and to extend their knowledge of the disease area.

With patients becoming better informed about the nature and management of their conditions, Rapid Reference is a timely new series that offer GPs easy access to the best information for patient care and management.
Szczegóły produktu
Mosby
35940
9780723433163
9780723433163

Opis

Rok wydania
2002
Numer wydania
1
Oprawa
miękka foliowana
Liczba stron
104
Wymiary (mm)
102 x 190
Waga (g)
195
  • 1. Introduction and Background
    2. Definition and epidemiology
    3. Aetiology
    4. Diagnosis
    5. Prevention
    -reduction/removal of risk factors
    -enhanced prenatal care
    -role of stress reduction
    -reduction of secondary forms of schizophrenia (eg drug induced, head trauma)
    -(pre)detection of high risk patients and patients with childhood neurodevelopmental deviance
    -prodromal detection and early intervention strategies
    6.Treatment
    -pharmacological
    -description of typical antipsychotics
    -types
    -mechanism(s) of action
    -efficacy
    -onset
    -overall
    -negative symptoms
    -depressive symptoms
    -cognition
    -hostility
    -adverse effects
    -motor-acute extrapyramidal, tardive dyskinesia, neuroleptic malignant syndrome
    -endocrine
    -metabolic
    -other
    -description of atypical antipsychotics
    -concept and validity of atypicality
    -mechanism(s) of action and relative receptor affinity profile of each atypical antipsychotic
    -clozapine
    -efficacy
    -onset
    -overall
    -negative symptoms
    -depressive symptoms
    -suicidality
    -cognition
    -hostility
    -adverse effects
    -agranulocystosis
    -seizures
    -sedation
    -drooling
    -weight gain
    -metabolic
    -other
    -risperidone
    -efficacy
    -onset
    -overall
    -negative symptoms
    -depressive symptoms
    -cognition
    -hostility
    -adverse effects
    -EPS
    -sedation
    -weight gain
    -metabolic
    -other
    -olanzapine
    -efficacy
    -onset
    -overall
    -negative symptoms
    -depressive symptoms
    -cognition
    -hostility
    -adverse effects
    -EPS
    -sedation
    -weight gain
    -metabolic
    -other
    -quetiapine
    -efficacy
    -onset
    -overall
    -negative symptoms
    -depressive symptoms
    -cognition
    -hostility
    -adverse effects
    -EPS
    -cataracts
    -sedation
    -weight gain
    -metabolic
    -other
    -ziprasidone
    -efficacy
    -onset
    -overall
    -negative symptoms
    -depressive symptoms
    -cognition
    -hostility
    -adverse effects
    -cardiotoxicity
    -EPS
    -sedation
    -weight gain
    -metabolic
    -other
    -description of other antipsychotic medications which are under debate as to whether they are typical or atypical agents
    -amisulpiride, sulpiride, zotepine
    -mechanism (s) of action
    -efficacy
    -description of other psychotropic medications which are used to augment the treatment response to either typical or atypical antipsychotic agents
    -nonpharmacological
    -electroconvulsive therapy
    -psychotherapies/psychosocial rehabilitation
    -individual supportive psychotherapy
    -cognitive behavioral therapy
    -cognitive remediation
    -compliance therapy
    -social skills therapy
    -assertive community treatment
    -case management
    -family therapy
    -mental health services and systems of care
    7. Management
    -domains of outcome, with emphasis on cognition
    -acute psychotic episode
    -first episode psychosis
    -choice of drug
    -dosing strategies
    -other aspects of care
    -maintenance therapy
    -initial choice of drug and sequential choice of agents
    -dosing and duration of treatment
    -other aspects of care
    -treatment refractory schizophrenia
    -assessment
    -sequential choice of agents
    -dosing and duration of treatment
    -role of augmentation
    -role of ECT
    -other aspects of care
    -comorbidities
    8. Future developments
    -drugs which are under development
    -new psychosocial approaches
    -Evidence-Based-Medicine and schizophrenia
    9. Frequently asked questions
    -is there a test for schizophrenia and can it be used to diagnose family members at risk?
    -does drug use/abuse cause schizophrenia?
    -how violent are people with schizophrenia?
    -if the illness is caught early can it be treated with a better outcome?
    -how long should a person be on medication?
    -how do you choose the right medication and how do you know its the right one?
    -how long should you wait on one drug before switching to another drug?
    -what is the best way of switching from one drug to another?
    -what is the best combination of treatment?
    -are other treatments (eg herbals, vitamins, meditation) helpful for schizophrenia?
    -how do you convince a person with schizophrenia to comply with their treatment?
    -if you suspect sombody has schizophrenia, who should you contact to get help for them?
    10. References
    11. Appendices
    Drug information
    Useful addresses and websites
Komentarze (0)

  • Często kupowane razem

    Brak dostępnych produktów